These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 8002681)
1. Steroid receptors in prostate cancer tissues and cells: pathophysiology, problems in methodology, clinical value and controversial questions. Pavone-Macaluso M; Carruba G; Castagnetta L Arch Esp Urol; 1994 Mar; 47(2):189-201. PubMed ID: 8002681 [TBL] [Abstract][Full Text] [Related]
2. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells. Gao J; Arnold JT; Isaacs JT Cancer Res; 2001 Jul; 61(13):5038-44. PubMed ID: 11431338 [TBL] [Abstract][Full Text] [Related]
3. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches. Hoffmann J; Sommer A J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262 [TBL] [Abstract][Full Text] [Related]
4. Regulation of prostatic growth and function by peptide growth factors. Culig Z; Hobisch A; Cronauer MV; Radmayr C; Hittmair A; Zhang J; Thurnher M; Bartsch G; Klocker H Prostate; 1996 Jun; 28(6):392-405. PubMed ID: 8650077 [TBL] [Abstract][Full Text] [Related]
5. Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R). Ling MT; Wang X; Lee DT; Tam PC; Tsao SW; Wong YC Carcinogenesis; 2004 Apr; 25(4):517-25. PubMed ID: 14688027 [TBL] [Abstract][Full Text] [Related]
6. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Bonkhoff H; Remberger K Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398 [TBL] [Abstract][Full Text] [Related]
7. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario. Carruba G J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930 [TBL] [Abstract][Full Text] [Related]
8. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines. Tørring N; Jørgensen PE; Sørensen BS; Nexø E Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639 [TBL] [Abstract][Full Text] [Related]
9. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells. Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates. De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409 [TBL] [Abstract][Full Text] [Related]
11. Proteomic identification of 14-3-3 sigma as a common component of the androgen receptor and the epidermal growth factor receptor signaling pathways of the human prostate epithelial cell line M12. Huang D; Liu X; Plymate SR; Idowu M; Grimes M; Best AM; McKinney JL; Ware JL Oncogene; 2004 Sep; 23(41):6881-9. PubMed ID: 15300238 [TBL] [Abstract][Full Text] [Related]
12. The role of stromal cells in prostate cancer development and progression. Condon MS; Bosland MC In Vivo; 1999; 13(1):61-5. PubMed ID: 10218135 [TBL] [Abstract][Full Text] [Related]
13. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action. Migliaccio A; Di Domenico M; Castoria G; Nanayakkara M; Lombardi M; de Falco A; Bilancio A; Varricchio L; Ciociola A; Auricchio F Cancer Res; 2005 Nov; 65(22):10585-93. PubMed ID: 16288052 [TBL] [Abstract][Full Text] [Related]
14. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells. Seth D; Shaw K; Jazayeri J; Leedman PJ Br J Cancer; 1999 May; 80(5-6):657-69. PubMed ID: 10360641 [TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor, neurotrophins and the metastatic cascade in prostate cancer. Montano X; Djamgoz MB FEBS Lett; 2004 Jul; 571(1-3):1-8. PubMed ID: 15280008 [TBL] [Abstract][Full Text] [Related]
16. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity. Siu SW; Lau KW; Tam PC; Shiu SY Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702 [TBL] [Abstract][Full Text] [Related]
17. Endocrine control of prostate cancer. Wilding G Cancer Surv; 1995; 23():43-62. PubMed ID: 7621473 [TBL] [Abstract][Full Text] [Related]
18. Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms. Scher HI; Sarkis A; Reuter V; Cohen D; Netto G; Petrylak D; Lianes P; Fuks Z; Mendelsohn J; Cordon-Cardo C Clin Cancer Res; 1995 May; 1(5):545-50. PubMed ID: 9816014 [TBL] [Abstract][Full Text] [Related]
19. cDNA microarray analysis identifies genes induced in common by peptide growth factors and androgen in human prostate epithelial cells. York TP; Plymate SR; Nelson PS; Eaves LJ; Webb HD; Ware JL Mol Carcinog; 2005 Dec; 44(4):242-51. PubMed ID: 16240454 [TBL] [Abstract][Full Text] [Related]
20. The importance of steroid hormones in prostate cancer. Wilding G Cancer Surv; 1992; 14():113-30. PubMed ID: 1423327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]